PB
Perseus-Soros Biopharmaceutical Fund
Private EquityActivePerseus-Soros Biopharmaceutical Fund, L.P. specializes in equity investments in private and public life science companies.
New York, United StatesFounded 2007
19
Investments
3
Exits
$1.2B
AUM
15.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Perseus-Soros Biopharmaceutical Fund.
Investment Thesis & Strategy
Perseus-Soros Biopharmaceutical Fund is a private equity firm that invests in both private and public life science companies, deploying capital across various stages of development.
Investment Activity
Deals per year over the last 8 years
1
20031
20041
20051
20064
20071
20080
20092
2010Portfolio Companies
Selected investments from their portfolio of 19 companies
N
Neurocrine Biosciences
Biotech · Growth, 0
C
Celator Pharmaceuticals
Biotech · Growth, 2010
A
Aratana Therapeutics
Biotech · Growth, 2010
E
Esperion Therapeutics
Biotech · Growth, 2008
P
Portola Pharmaceuticals
Biotech · Growth, 2007
A
Achillion Pharmaceuticals
Biotech · Growth, 2007
S
Sucampo Pharmaceuticals
Biotech · Growth, 2007
I
Inotek Pharmaceuticals
Biotech · Growth, 2007
S
Synta Pharmaceuticals
Biotech · Growth, 2006
A
Amicus Therapeutics
Biotech · Growth, 2005
M
Medivation
Biotech · Growth, 2004
V
Vanda Pharmaceuticals
Biotech · Growth, 2003
Notable Exits
CompanyTypeYearValue / Acquirer
ARCA biopharmaAcquisition2024—
Portola PharmaceuticalsIPO2013—
Esperion TherapeuticsIPO2013—
Frequently Asked Questions
Perseus-Soros Biopharmaceutical Fund focuses on Series B, Series C+ stage investments.